Population
HeLa cell extracts, E. coli expressing poliovirus 2A protease, and purified eukaryotic initiation factor 3…
Comparison
Addition of purified eIF-3 to an in vitro… vs Reaction mixtures without added eIF-3 or with…
Design
Preclinical
Authors
Loading...
Supports eIF-3 as potential antiviral target; leaves open in vivo validation and clinical translation.
Eukaryotic initiation factor 3 is required for the poliovirus 2A protease-induced cleavage of p220, a critical step in the viral shut-off of host cell protein synthesis.
Wyckoff et al. (1990) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: